Albireo Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- S&P 500, Nasdaq fall as investors juggle earnings, Mideast risks and tariffs
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil retreats from above $100, still set for weekly rise on Middle East escalation
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- Meta’s new seller app hits eBay where it hurts most
Albireo Pharma (ALBO) Tops Q2 EPS by 8c
August 8, 2019 7:38 AM EDTAlbireo Pharma (NASDAQ: ALBO) reported Q2 EPS of ($1.35), $0.08 better than the analyst estimate of ($1.43). Revenue for the quarter came in at $1.25 million versus the consensus estimate of $770 thousand.
The momentum is building for Albireo, as we advance programs on multiple fronts and ramp up... More
